{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:27:11Z","timestamp":1794274031813,"version":"4.9.0"},"reference-count":165,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:p>Maternal use of certain drugs during pregnancy can result in transient neonatal signs consistent with withdrawal or acute toxicity or cause sustained signs consistent with a lasting drug effect. In addition, hospitalized infants who are treated with opioids or benzodiazepines to provide analgesia or sedation may be at risk for manifesting signs of withdrawal. This statement updates information about the clinical presentation of infants exposed to intrauterine drugs and the therapeutic options for treatment of withdrawal and is expanded to include evidence-based approaches to the management of the hospitalized infant who requires weaning from analgesics or sedatives.<\/jats:p>","DOI":"10.1542\/peds.2011-3212","type":"journal-article","created":{"date-parts":[[2012,1,31]],"date-time":"2012-01-31T00:38:25Z","timestamp":1327970305000},"page":"e540-e560","source":"Crossref","is-referenced-by-count":738,"title":["Neonatal Drug Withdrawal"],"prefix":"10.1542","volume":"129","author":[{"given":"Mark L.","family":"Hudak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"THE COMMITTEE ON DRUGS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"THE COMMITTEE ON FETUS AND NEWBORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A. C.","family":"Frattarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Galinkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Van Den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ann","family":"Papile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill E.","family":"Baley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod K.","family":"Bhutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar A.","family":"Carlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Polin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi L.","family":"Watterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2012,2,1]]},"reference":[{"key":"2021120903122609600_B1"},{"issue":"10","key":"2021120903122609600_B2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.jp.7211378","article-title":"Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure","volume":"25","author":"Bada","year":"2005","journal-title":"J Perinatol"},{"key":"2021120903122609600_B3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0074-7742(09)85009-5","article-title":"Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations","volume":"85","author":"Campolongo","year":"2009","journal-title":"Int Rev Neurobiol"},{"issue":"5","key":"2021120903122609600_B4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1080\/09595230701494416","article-title":"Using population data to examine the prevalence and correlates of neonatal abstinence syndrome","volume":"26","author":"Burns","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"2021120903122609600_B5","first-page":"259.e1","article-title":"Current trends in narcotic use in pregnancy and neonatal outcomes","volume-title":"Am J Obstet Gynecol","author":"Kellogg","year":"2011"},{"issue":"3","key":"2021120903122609600_B6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1542\/peds.54.3.300","article-title":"The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants","volume":"54","author":"Harper","year":"1974","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903122609600_B7","first-page":"360","article-title":"Narcotic addiction, pregnancy, and the newborn","volume":"132","author":"Fricker","year":"1978","journal-title":"Am J Dis Child"},{"issue":"2","key":"2021120903122609600_B8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9378(16)33250-1","article-title":"Observation and treatment of neonatal narcotic withdrawal","volume":"127","author":"Madden","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"4 pt 1","key":"2021120903122609600_B9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(76)80027-3","article-title":"A study of factors that influence the severity of neonatal narcotic withdrawal","volume":"88","author":"Ostrea","year":"1976","journal-title":"J Pediatr"},{"issue":"1","key":"2021120903122609600_B10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-3476(77)80785-3","article-title":"Withdrawal symptoms in neonates from intrauterine exposure to diazepam","volume":"90","author":"Rementer\u00eda","year":"1977","journal-title":"J Pediatr"},{"issue":"2","key":"2021120903122609600_B11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0002-9378(16)33306-3","article-title":"Chloriazepoxide withdrawal in the neonate","volume":"124","author":"Athinarayanan","year":"1976","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120903122609600_B12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.1972.03200150049012","article-title":"Barbiturate withdrawal syndrome in a passively addicted infant","volume":"221","author":"Bleyer","year":"1972","journal-title":"JAMA"},{"issue":"2","key":"2021120903122609600_B13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0022-3476(72)80577-8","article-title":"Maternal barbiturate utilization and neonatal withdrawal symptomatology","volume":"80","author":"Desmond","year":"1972","journal-title":"J Pediatr"},{"issue":"4","key":"2021120903122609600_B14","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-3476(77)80387-9","article-title":"Withdrawal symptoms in infants with the fetal alcohol syndrome","volume":"90","author":"Pierog","year":"1977","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903122609600_B15","first-page":"714","article-title":"Acute alcohol withdrawal syndrome in a newborn","volume":"113","author":"Nichols","year":"1967","journal-title":"Am J Dis Child"},{"issue":"5","key":"2021120903122609600_B16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0892-0362(01)00166-0","article-title":"Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure","volume":"23","author":"Eyler","year":"2001","journal-title":"Neurotoxicol Teratol"},{"issue":"9","key":"2021120903122609600_B17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/archpedi.159.9.824","article-title":"Acute neonatal effects of cocaine exposure during pregnancy","volume":"159","author":"Bauer","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"3","key":"2021120903122609600_B18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0022-3476(86)80896-4","article-title":"Perinatal cerebral infarction and maternal cocaine use","volume":"108","author":"Chasnoff","year":"1986","journal-title":"J Pediatr"},{"issue":"8","key":"2021120903122609600_B19","first-page":"905","article-title":"Perinatal outcome of infants exposed to cocaine and\/or heroin in utero","volume":"143","author":"Fulroth","year":"1989","journal-title":"Am J Dis Child"},{"issue":"2","key":"2021120903122609600_B20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0887-8994(93)90045-E","article-title":"Neurologic findings in neonates with intrauterine cocaine exposure","volume":"9","author":"Chiriboga","year":"1993","journal-title":"Pediatr Neurol"},{"issue":"2","key":"2021120903122609600_B21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.84.2.205","article-title":"Maternal cocaine use during pregnancy: effect on the newborn infant","volume":"84","author":"Hadeed","year":"1989","journal-title":"Pediatrics"},{"issue":"2 pt 1","key":"2021120903122609600_B22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.96.2.259","article-title":"Neurologic manifestations of in utero cocaine exposure in near-term and term infants","volume":"96","author":"King","year":"1995","journal-title":"Pediatrics"},{"key":"2021120903122609600_B23","volume-title":"Neonatal Behavioral Assessment Scale. Clinics in Developmental Medicine. No 88","author":"Brazelton","year":"1984","edition":"2nd ed."},{"issue":"2","key":"2021120903122609600_B24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1542\/peds.113.2.357","article-title":"Abnormal auditory brainstem response among infants with prenatal cocaine exposure","volume":"113","author":"Tan-Laxa","year":"2004","journal-title":"Pediatrics"},{"issue":"6","key":"2021120903122609600_B25","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archneur.1988.00520300069021","article-title":"One-year follow-up of infants with abstinence-associated seizures","volume":"45","author":"Doberczak","year":"1988","journal-title":"Arch Neurol"},{"issue":"1","key":"2021120903122609600_B26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1542\/peds.98.1.76","article-title":"Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance","volume":"98","author":"Tronick","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903122609600_B27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00004703-200302000-00006","article-title":"Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term","volume":"24","author":"Smith","year":"2003","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"2021120903122609600_B28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0145-2134(88)90067-1","article-title":"Predictive indicators for adjustment in 4-year-old children whose mothers used amphetamine during pregnancy","volume":"12","author":"Billing","year":"1988","journal-title":"Child Abuse Negl"},{"issue":"2","key":"2021120903122609600_B29","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1651-2227.1996.tb13993.x","article-title":"Amphetamine addiction during pregnancy: 14-year follow-up of growth and school performance","volume":"85","author":"Cernerud","year":"1996","journal-title":"Acta Paediatr"},{"issue":"6","key":"2021120903122609600_B30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00023210-200923060-00004","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"23","author":"Alwan","year":"2009","journal-title":"CNS Drugs"},{"key":"2021120903122609600_B31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1192\/bjp.171.4.391c","article-title":"Paroxetine withdrawal syndrome in a neonate","volume":"171","author":"Dahl","year":"1997","journal-title":"Br J Psychiatry"},{"issue":"9458","key":"2021120903122609600_B32","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":"Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"issue":"14","key":"2021120903122609600_B33","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"issue":"9","key":"2021120903122609600_B34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00048670903107583","article-title":"Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study","volume":"43","author":"Galbally","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"2021120903122609600_B35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0269881105056554","article-title":"Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?","volume":"19","author":"Haddad","year":"2005","journal-title":"J Psychopharmacol"},{"issue":"3","key":"2021120903122609600_B36","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1080\/080352501300067596","article-title":"Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors","volume":"90","author":"Nordeng","year":"2001","journal-title":"Acta Paediatr"},{"issue":"11","key":"2021120903122609600_B37","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120903122609600_B38","doi-asserted-by":"crossref","first-page":"F147","DOI":"10.1136\/fn.85.2.F145g","article-title":"Neonatal paroxetine withdrawal syndrome or actually serotonin syndrome?","volume":"85","author":"Isbister","year":"2001","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"7","key":"2021120903122609600_B39","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":"Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"2021120903122609600_B40","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1017\/S003329170600835X","article-title":"To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects","volume":"36","author":"Austin","year":"2006","journal-title":"Psychol Med"},{"issue":"3","key":"2021120903122609600_B41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1092852900027449","article-title":"On categorizing gestational, birth, and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome","volume":"15","author":"Gentile","year":"2010","journal-title":"CNS Spectr"},{"issue":"2","key":"2021120903122609600_B42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1542\/peds.2004-0420","article-title":"Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure","volume":"115","author":"Oberlander","year":"2005","journal-title":"Pediatrics"},{"issue":"7","key":"2021120903122609600_B43","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00002018-200528070-00002","article-title":"Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy: effects on the infant","volume":"28","author":"Nordeng","year":"2005","journal-title":"Drug Saf"},{"issue":"1","key":"2021120903122609600_B44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/157488606775252593","article-title":"Safety of selective serotonin reuptake inhibitors in pregnancy","volume":"1","author":"De las Cuevas","year":"2006","journal-title":"Curr Drug Saf"},{"issue":"6","key":"2021120903122609600_B45","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.161.6.1066","article-title":"Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants","volume":"161","author":"Weissman","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"4","key":"2021120903122609600_B46","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-0326","article-title":"Psychotropic drug use during breastfeeding: a review of the evidence","volume":"124","author":"Fortinguerra","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903122609600_B47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.clpt.6100095","article-title":"Pharmacogenetics of opioids","volume":"81","author":"Somogyi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"24","key":"2021120903122609600_B48","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120903122609600_B49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1542\/peds.48.2.178","article-title":"Neonatal narcotic addiction: 10 year observation","volume":"48","author":"Zelson","year":"1971","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903122609600_B50","first-page":"58","article-title":"Late presentation of drug withdrawal symptoms in newborns","volume":"127","author":"Kandall","year":"1974","journal-title":"Am J Dis Child"},{"issue":"3","key":"2021120903122609600_B51","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2021120903122609600_B52","first-page":"286","article-title":"Narcotic withdrawal reactions in the newborn","volume":"94","author":"Steg","year":"1957","journal-title":"AMA J Dis Child"},{"issue":"1","key":"2021120903122609600_B53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1360-0443.2003.00245.x","article-title":"Neonatal outcome following buprenorphine maintenance during conception and throughout pregnancy","volume":"98","author":"Schindler","year":"2003","journal-title":"Addiction"},{"issue":"11","key":"2021120903122609600_B54","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1046\/j.1360-0443.2003.00551.x","article-title":"Buprenorphine withdrawal syndrome in newborns: a report of 13 cases","volume":"98","author":"Kayemba-Kay\u2019s","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"2021120903122609600_B55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1360-0443.2003.00600.x","article-title":"Buprenorphine in pregnant opioid-dependent women: first results of a prospective study","volume":"99","author":"Lacroix","year":"2004","journal-title":"Addiction"},{"issue":"4","key":"2021120903122609600_B56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3476(77)80523-4","article-title":"Neonatal seizures associated with narcotic withdrawal","volume":"91","author":"Herzlinger","year":"1977","journal-title":"J Pediatr"},{"issue":"1","key":"2021120903122609600_B57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0376-8716(88)90009-9","article-title":"Sleep in babies born to chronically heroin addicted mothers. A follow up study","volume":"21","author":"Pinto","year":"1988","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"2021120903122609600_B58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/adc.64.2.235","article-title":"Neonatal behavior after drug dependent pregnancy","volume":"64","author":"van Baar","year":"1989","journal-title":"Arch Dis Child"},{"issue":"1\u20132","key":"2021120903122609600_B59","first-page":"113","article-title":"Neonatal abstinence syndrome: recognition and diagnosis","volume":"2","author":"Desmond","year":"1975","journal-title":"Addict Dis"},{"issue":"5","key":"2021120903122609600_B60","first-page":"529","article-title":"Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride","volume":"131","author":"Prenner","year":"1977","journal-title":"Am J Dis Child"},{"issue":"5","key":"2021120903122609600_B61","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00000542-199011000-00006","article-title":"Oral midazolam preanesthetic medication in pediatric outpatients","volume":"73","author":"Feld","year":"1990","journal-title":"Anesthesiology"},{"issue":"4","key":"2021120903122609600_B62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0002-9378(77)90588-9","article-title":"Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome","volume":"129","author":"Harper","year":"1977","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120903122609600_B63","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00952997609077202","article-title":"Relationship of neonatal withdrawal to maternal methadone dose","volume":"3","author":"Strauss","year":"1976","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"6","key":"2021120903122609600_B64","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","article-title":"Neonatal opiate abstinence syndrome in term and preterm infants","volume":"118","author":"Doberczak","year":"1991","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903122609600_B65","first-page":"936","article-title":"Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal","volume":"81","author":"Doberczak","year":"1993","journal-title":"Obstet Gynecol"},{"issue":"1\u20132","key":"2021120903122609600_B66","first-page":"169","article-title":"Disposition of methadone and its relationship to severity of withdrawal in the newborn","volume":"2","author":"Rosen","year":"1975","journal-title":"Addict Dis"},{"issue":"6","key":"2021120903122609600_B67","first-page":"1244","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2021120903122609600_B68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1479-828X.2010.01168.x","article-title":"Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy","volume":"50","author":"Liu","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"2021120903122609600_B69","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0002-9378(98)70379-5","article-title":"Methadone maintenance in pregnancy: a reappraisal","volume":"179","author":"Brown","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"2021120903122609600_B70","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1440-1754.1991.tb00360.x","article-title":"Methadone levels and neonatal withdrawal","volume":"27","author":"Mack","year":"1991","journal-title":"J Paediatr Child Health"},{"issue":"2","key":"2021120903122609600_B71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","article-title":"Maternal methadone dose and neonatal withdrawal","volume":"189","author":"Berghella","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2021120903122609600_B72","doi-asserted-by":"crossref","first-page":"F390","DOI":"10.1136\/adc.2003.036863","article-title":"Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?","volume":"89","author":"Kuschel","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"3","key":"2021120903122609600_B73","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"issue":"12","key":"2021120903122609600_B74","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome\u2014systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"issue":"5","key":"2021120903122609600_B75","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1067\/mob.2002.127132","article-title":"Methadone trough levels in pregnancy","volume":"187","author":"Drozdick","year":"2002","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2021120903122609600_B76","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/000992287501400613","article-title":"A proposed narcotic withdrawal score for use with newborn infants. A pragmatic evaluation of its efficacy","volume":"14","author":"Lipsitz","year":"1975","journal-title":"Clin Pediatr (Phila)"},{"issue":"1\u20132","key":"2021120903122609600_B77","first-page":"19","article-title":"Assessment and treatment of abstinence in the infant of the drug-dependent mother","volume":"12","author":"Finnegan","year":"1975","journal-title":"Int Clin Pharmacol Biopharm"},{"issue":"4","key":"2021120903122609600_B78","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1515\/JPM.2007.063","article-title":"Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome","volume":"35","author":"Dysart","year":"2007","journal-title":"J Perinat Med"},{"issue":"1","key":"2021120903122609600_B79","doi-asserted-by":"crossref","first-page":"F2","DOI":"10.1136\/fn.88.1.F2","article-title":"Treatment of neonatal abstinence syndrome","volume":"88","author":"Johnson","year":"2003","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"11","key":"2021120903122609600_B80","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1056\/NEJM198509123131105","article-title":"Cocaine use in pregnancy","volume":"313","author":"Chasnoff","year":"1985","journal-title":"N Engl J Med"},{"issue":"3","key":"2021120903122609600_B81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"8655","key":"2021120903122609600_B82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0140-6736(89)90214-6","article-title":"Naloxone hazard in infant of opioid abuser","volume":"2","author":"Gibbs","year":"1989","journal-title":"Lancet"},{"issue":"6","key":"2021120903122609600_B83","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1542\/peds.82.6.888","article-title":"Cocaine use during pregnancy: prevalence and correlates","volume":"82","author":"Frank","year":"1988","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903122609600_B84","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0892-0362(87)90017-1","article-title":"Cocaine use in pregnancy: perinatal morbidity and mortality","volume":"9","author":"Chasnoff","year":"1987","journal-title":"Neurotoxicol Teratol"},{"issue":"5","key":"2021120903122609600_B85","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/0002-9378(88)90422-X","article-title":"Ultrasonic growth parameters in fetuses of mothers with primary addiction to cocaine","volume":"159","author":"Mitchell","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"23","key":"2021120903122609600_B86","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJM198612043152327","article-title":"Medical complications of cocaine abuse","volume":"315","author":"Cregler","year":"1986","journal-title":"N Engl J Med"},{"issue":"12","key":"2021120903122609600_B87","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1001\/jama.1989.03420120079030","article-title":"Temporal patterns of cocaine use in pregnancy. Perinatal outcome","volume":"261","author":"Chasnoff","year":"1989","journal-title":"JAMA"},{"issue":"2","key":"2021120903122609600_B88","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0020-7292(91)90774-Y","article-title":"Cocaine abuse: implications for pregnancy. ACOG Committee opinion: Committee on Obstetrics: Maternal and Fetal Medicine number 81\u2014March 1990","volume":"36","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"issue":"4","key":"2021120903122609600_B89","first-page":"324","article-title":"Drug use in pregnancy: to test, to tell\u2014legal implications for the physician","volume":"15","author":"Horowitz","year":"1991","journal-title":"Semin Perinatol"},{"key":"2021120903122609600_B90","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1542\/neo.4-9-e228","article-title":"Prenatal substance exposure: maternal screening and neonatal identification and management","volume":"4(9)","author":"Chasnoff","year":"2003","journal-title":"NeoReviews"},{"issue":"4","key":"2021120903122609600_B91","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1067\/mob.2001.109939","article-title":"Screening for substance use in pregnancy: a practical approach for the primary care physician","volume":"184","author":"Chasnoff","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"2021120903122609600_B92","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1542\/neo.4-9-e236","article-title":"New methods for neonatal drug screening","volume":"4(9)","author":"Chan","year":"2003","journal-title":"NeoReviews"},{"issue":"3","key":"2021120903122609600_B93","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00129804-200505000-00003","article-title":"Identification and management of neonatal abstinence syndrome","volume":"28","author":"Beauman","year":"2005","journal-title":"J Infus Nurs"},{"issue":"8","key":"2021120903122609600_B94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1891\/0730-0832.18.8.55","article-title":"Drug-of-abuse testing in the neonate","volume":"18","author":"Reinarz","year":"1999","journal-title":"Neonatal Netw"},{"issue":"3","key":"2021120903122609600_B95","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-3476(89)80860-1","article-title":"Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing","volume":"115","author":"Ostrea","year":"1989","journal-title":"J Pediatr"},{"issue":"3","key":"2021120903122609600_B96","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3476(05)83291-3","article-title":"Meconium analysis for improved identification of infants exposed to cocaine in utero","volume":"125","author":"Ryan","year":"1994","journal-title":"J Pediatr"},{"issue":"3","key":"2021120903122609600_B97","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1067\/mpd.2001.111429","article-title":"Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis","volume":"138","author":"Ostrea","year":"2001","journal-title":"J Pediatr"},{"issue":"4","key":"2021120903122609600_B98","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00007691-200308000-00002","article-title":"Neonatal hair analysis contribution to establishing a gestational drug exposure profile and predicting a withdrawal syndrome","volume":"25","author":"Vinner","year":"2003","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2021120903122609600_B99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.jp.7211416","article-title":"Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium","volume":"26","author":"Montgomery","year":"2006","journal-title":"J Perinatol"},{"issue":"6","key":"2021120903122609600_B100","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1542\/peds.101.6.1079","article-title":"Neonatal drug withdrawal","volume":"101","author":"American Academy of Pediatrics, Committee on Drugs","year":"1998","journal-title":"Pediatrics"},{"key":"2021120903122609600_B101","article-title":"Neonatal abstinence","volume-title":"Current Therapy in Neonatal\u2013Perinatal Medicine","author":"Finnegan","year":"1990","edition":"2nd ed."},{"issue":"1","key":"2021120903122609600_B102","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jp.7211427","article-title":"Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey","volume":"26","author":"Sarkar","year":"2006","journal-title":"J Perinatol"},{"issue":"2","key":"2021120903122609600_B103","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/00952998108999125","article-title":"The Neonatal Narcotic Withdrawal Index: a device for the improvement of care in the abstinence syndrome","volume":"8","author":"Green","year":"1981","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"2021120903122609600_B104","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1360-0443.2009.02802.x","article-title":"Finnegan neonatal abstinence scoring system: normal values for first 3 days and weeks 5-6 in non-addicted infants","volume":"105","author":"Zimmermann-Baer","year":"2010","journal-title":"Addiction"},{"key":"2021120903122609600_B105","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0031-3955(16)31370-0","article-title":"Management of the narcotic withdrawal syndrome in the neonate","volume":"10","author":"Hill","year":"1963","journal-title":"Pediatr Clin North Am"},{"issue":"1\u20132","key":"2021120903122609600_B106","first-page":"333","article-title":"Somatic growth effects of perinatal addiction","volume":"2","author":"Wilson","year":"1975","journal-title":"Addict Dis"},{"issue":"6","key":"2021120903122609600_B107","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-1561","article-title":"Effects of breast milk on the severity and outcome of neonatal abstinence syndrome among infants of drug-dependent mothers","volume":"117","author":"Abdel-Latif","year":"2006","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903122609600_B108","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/jp.2010.66","article-title":"Maternal and neonatal factors impacting response to methadone therapy in infants treated for neonatal abstinence syndrome","volume":"31","author":"Isemann","year":"2011","journal-title":"J Perinatol"},{"issue":"1","key":"2021120903122609600_B109","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1542\/peds.2007-1182","article-title":"Methadone maintenance and breastfeeding in the neonatal period","volume":"121","author":"Jansson","year":"2008","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903122609600_B110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/bfm.2007.0032","article-title":"Methadone maintenance and long-term lactation","volume":"3","author":"Jansson","year":"2008","journal-title":"Breastfeed Med"},{"issue":"4","key":"2021120903122609600_B111","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/bfm.2009.9987","article-title":"ABM clinical protocol #21: guidelines for breastfeeding and the drug-dependent woman","volume":"4","author":"Jansson","year":"2009","journal-title":"Breastfeed Med"},{"issue":"8","key":"2021120903122609600_B112","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3928\/0090-4481-19920801-08","article-title":"The care of alcohol- and drug-affected infants","volume":"21","author":"Bays","year":"1992","journal-title":"Pediatr Ann"},{"issue":"4","key":"2021120903122609600_B113","doi-asserted-by":"crossref","first-page":"F249","DOI":"10.1136\/adc.2008.152769","article-title":"Management of neonatal abstinence syndrome: a national survey and review of practice","volume":"94","author":"O\u2019Grady","year":"2009","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021120903122609600_B114","first-page":"353","article-title":"Neonatal abstinence syndrome, pharmacotherapy and developmental outcome","volume":"8","author":"Kaltenbach","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"issue":"4 pt 1","key":"2021120903122609600_B115","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-3476(76)80026-1","article-title":"Neonatal narcotic abstinence: effects of pharmacotherapeutic agents and maternal drug usage on nutritive sucking behavior","volume":"88","author":"Kron","year":"1976","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903122609600_B116","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1542\/peds.49.6.928","article-title":"Diazepam (Valium) for neonatal narcotic withdrawal: a question of safety","volume":"49","author":"Schiff","year":"1972","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903122609600_B117","first-page":"CD002059","article-title":"Opiate treatment for opiate withdrawal in newborn infants","author":"Osborn","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021120903122609600_B118","first-page":"CD002053","article-title":"Sedatives for opiate withdrawal in newborn infants","author":"Osborn","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2021120903122609600_B119","unstructured":"Khoo KT. The Effectiveness of Three Treatment Regimens Used in the Management of Neonatal Abstinence Syndrome [thesis for PhD]. Melbourne, Australia: University of Melbourne; 1995"},{"key":"2021120903122609600_B120","first-page":"282","article-title":"An evaluation of neonatal abstinence treatment modalities","volume":"49","author":"Finnegan","year":"1984","journal-title":"NIDA Res Monogr"},{"issue":"4","key":"2021120903122609600_B121","doi-asserted-by":"crossref","first-page":"F300","DOI":"10.1136\/adc.2003.033555","article-title":"A randomised controlled trial of morphine versus phenobarbitone for neonatal abstinence syndrome","volume":"89","author":"Jackson","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"4","key":"2021120903122609600_B122","first-page":"378","article-title":"Opiate v CNS depressant therapy in neonatal drug abstinence syndrome","volume":"137","author":"Kandall","year":"1983","journal-title":"Am J Dis Child"},{"issue":"12","key":"2021120903122609600_B123","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpedi.1983.02140380026008","article-title":"Neonatal methadone withdrawal. Effect of two treatment regimens","volume":"137","author":"Carin","year":"1983","journal-title":"Am J Dis Child"},{"issue":"5","key":"2021120903122609600_B124","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mpd.2002.123099","article-title":"Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants","volume":"140","author":"Coyle","year":"2002","journal-title":"J Pediatr"},{"issue":"3","key":"2021120903122609600_B125","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0022-3476(69)80281-7","article-title":"The course of the heroin withdrawal syndrome in newborn infants treated with phenobarbital or chlorpromazine","volume":"75","author":"Kahn","year":"1969","journal-title":"J Pediatr"},{"issue":"1","key":"2021120903122609600_B126","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.07.001","article-title":"Therapy of the neonatal abstinence syndrome with tincture of opium or morphine drops","volume":"77","author":"Langenfeld","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"2021120903122609600_B127","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.adnc.2005.06.003","article-title":"A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations","volume":"5","author":"Lainwala","year":"2005","journal-title":"Adv Neonatal Care"},{"issue":"2\u20133","key":"2021120903122609600_B128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.drugalcdep.2006.08.024","article-title":"Management of neonatal abstinence syndrome in neonates born to opioid maintained women","volume":"87","author":"Ebner","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"2021120903122609600_B129","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-0571","article-title":"Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial","volume":"122","author":"Kraft","year":"2008","journal-title":"Pediatrics"},{"issue":"8090","key":"2021120903122609600_B130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(78)92823-4","article-title":"Clonidine blocks acute opiate-withdrawal symptoms","volume":"2","author":"Gold","year":"1978","journal-title":"Lancet"},{"issue":"1","key":"2021120903122609600_B131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1542\/peds.98.1.135","article-title":"The management of opioid and benzodiazepine dependence in infants, children, and adolescents","volume":"98","author":"Yaster","year":"1996","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903122609600_B132","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0165-1781(84)90039-8","article-title":"Clonidine treatment of neonatal narcotic abstinence syndrome","volume":"13","author":"Hoder","year":"1984","journal-title":"Psychiatry Res"},{"issue":"5","key":"2021120903122609600_B133","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"2021120903122609600_B134","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/15563650902980019","article-title":"Use of clonidine in the prevention and management of neonatal abstinence syndrome","volume":"47","author":"Leikin","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"2021120903122609600_B135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1651-2227.2009.01547.x","article-title":"Treatment of neonatal abstinence syndrome with clonidine and chloral hydrate","volume":"99","author":"Esmaeili","year":"2010","journal-title":"Acta Paediatr"},{"issue":"10","key":"2021120903122609600_B136","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1651-2227.2008.00918.x","article-title":"Comparison of chlorpromazine versus morphine hydrochloride for treatment of neonatal abstinence syndrome","volume":"97","author":"Mazurier","year":"2008","journal-title":"Acta Paediatr"},{"issue":"13","key":"2021120903122609600_B137","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0024-3205(79)90059-6","article-title":"Perinatal methadone addiction affects brain synaptic development of biogenic amine systems in the rat","volume":"24","author":"Slotkin","year":"1979","journal-title":"Life Sci"},{"issue":"4\u20136","key":"2021120903122609600_B138","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000112395","article-title":"Effects of prenatal methadone on rat brain catecholamines","volume":"3","author":"McGinty","year":"1980","journal-title":"Dev Neurosci"},{"issue":"2","key":"2021120903122609600_B139","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10550881003684871","article-title":"Prenatal drug exposure: infant and toddler outcomes","volume":"29","author":"Bandstra","year":"2010","journal-title":"J Addict Dis"},{"issue":"4","key":"2021120903122609600_B140","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0022-3476(05)82419-9","article-title":"Changes in the pharmacodynamic response to fentanyl in neonates during continuous infusion","volume":"119","author":"Arnold","year":"1991","journal-title":"J Pediatr"},{"issue":"6","key":"2021120903122609600_B141","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/00000542-199012000-00011","article-title":"Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation","volume":"73","author":"Arnold","year":"1990","journal-title":"Anesthesiology"},{"issue":"5","key":"2021120903122609600_B142","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-199405000-00009","article-title":"Prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion","volume":"22","author":"Katz","year":"1994","journal-title":"Crit Care Med"},{"issue":"4","key":"2021120903122609600_B143","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1345\/aph.1C324","article-title":"Opioid withdrawal in critically ill neonates","volume":"37","author":"Dominguez","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"4","key":"2021120903122609600_B144","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00003246-199804000-00015","article-title":"Acute withdrawal syndrome related to the administration of analgesic and sedative medications in adult intensive care unit patients","volume":"26","author":"Cammarano","year":"1998","journal-title":"Crit Care Med"},{"issue":"5","key":"2021120903122609600_B145","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4037\/ajcc1998.7.5.364","article-title":"Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation","volume":"7","author":"Franck","year":"1998","journal-title":"Am J Crit Care"},{"issue":"5","key":"2021120903122609600_B146","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00003246-199405000-00001","article-title":"Fentanyl infusion and weaning in the pediatric intensive care unit: toward science-based practice","volume":"22","author":"Carr","year":"1994","journal-title":"Crit Care Med"},{"issue":"11","key":"2021120903122609600_B147","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/00003246-199011000-00024","article-title":"Methadone as treatment for iatrogenic narcotic dependency in pediatric intensive care unit patients","volume":"18","author":"Tobias","year":"1990","journal-title":"Crit Care Med"},{"key":"2021120903122609600_B148","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.jp.7211712","article-title":"Pharmacological approaches to the management of pain in the neonatal intensive care unit","volume":"27","author":"Anand","year":"2007","journal-title":"J Perinatol"},{"issue":"2","key":"2021120903122609600_B149","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00130478-200010000-00005","article-title":"Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care unit patients","volume":"1","author":"Robertson","year":"2000","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2021120903122609600_B150","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00130478-200110000-00009","article-title":"Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients","volume":"2","author":"Meyer","year":"2001","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2021120903122609600_B151","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1213\/01.ane.0000202395.94542.3e","article-title":"A prospective evaluation of opioid weaning in opioid-dependent pediatric critical care patients","volume":"102","author":"Berens","year":"2006","journal-title":"Anesth Analg"},{"issue":"6","key":"2021120903122609600_B152","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.iccn.2004.07.008","article-title":"Opioid and benzodiazepine withdrawal symptoms in paediatric intensive care patients","volume":"20","author":"Franck","year":"2004","journal-title":"Intensive Crit Care Nurs"},{"issue":"8","key":"2021120903122609600_B153","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00134-007-0696-x","article-title":"Withdrawal symptoms in children after long-term administration of sedatives and\/or analgesics: a literature review. \u201cAssessment remains troublesome\u201d","volume":"33","author":"Ista","year":"2007","journal-title":"Intensive Care Med"},{"issue":"4","key":"2021120903122609600_B154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1460-9592.2003.01219.x","article-title":"Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward","volume":"14","author":"Cunliffe","year":"2004","journal-title":"Paediatr Anaesth"},{"issue":"8","key":"2021120903122609600_B155","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/CCM.0b013e318181600d","article-title":"Withdrawal symptoms in critically ill children after long-term administration of sedatives and\/or analgesics: a first evaluation","volume":"36","author":"Ista","year":"2008","journal-title":"Crit Care Med"},{"issue":"4","key":"2021120903122609600_B156","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.siny.2006.02.008","article-title":"Pain control: opioid dosing, population kinetics and side-effects","volume":"11","author":"Simons","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"issue":"1","key":"2021120903122609600_B157","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00134-006-0387-z","article-title":"Effects of low-dose naloxone on opioid therapy in pediatric patients: a retrospective case-control study","volume":"33","author":"Cheung","year":"2007","journal-title":"Intensive Care Med"},{"issue":"5","key":"2021120903122609600_B158","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1468","article-title":"Effect of low-dose naloxone infusion on fentanyl requirements in critically ill children","volume":"121","author":"Darnell","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903122609600_B159","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1542\/peds.2004-2491","article-title":"Breastfeeding and the use of human milk","volume":"115","author":"Gartner","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021120903122609600_B160","first-page":"231","article-title":"Pharmacologic management of acute abstinence syndromes","volume":"45","author":"Milhorn","year":"1992","journal-title":"Am Fam Physician"},{"issue":"9","key":"2021120903122609600_B161","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00007611-198809000-00006","article-title":"Neonatal withdrawal symptoms after chronic maternal ingestion of caffeine","volume":"81","author":"McGowan","year":"1988","journal-title":"South Med J"},{"issue":"5","key":"2021120903122609600_B162","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/adc.54.5.405-a","article-title":"Neonatal effects of maternal clomipramine therapy","volume":"54","author":"Musa","year":"1979","journal-title":"Arch Dis Child"},{"issue":"5","key":"2021120903122609600_B163","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1542\/peds.52.5.714","article-title":"Neonatal withdrawal following maternal ingestion of ethchlorvynol (Placidyl)","volume":"52","author":"Rumack","year":"1973","journal-title":"Pediatrics"},{"issue":"5","key":"2021120903122609600_B164","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/000992287701600503","article-title":"Neonatal withdrawal symptoms associated with glutethimide (Doriden) addiction in the mother during pregnancy","volume":"16","author":"Reveri","year":"1977","journal-title":"Clin Pediatr (Phila)"},{"key":"2021120903122609600_B165","first-page":"235","article-title":"Behavioral alterations in infants born to mothers on psychoactive medication during pregnancy","volume-title":"Congenital Mental Retardation","author":"Desmond","year":"1969"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/129\/2\/e540\/1056374\/peds_2011-3212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/129\/2\/e540\/1056374\/peds_2011-3212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:53:15Z","timestamp":1713448395000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/129\/2\/e540\/32573\/Neonatal-Drug-Withdrawal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":165,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,1]]},"published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2011-3212","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}